US Stock MarketDetailed Quotes

NTLA Intellia Therapeutics

Watchlist
  • 20.760
  • +0.740+3.70%
Close Apr 26 16:00 ET
  • 20.800
  • +0.040+0.19%
Post 18:11 ET
2.00BMarket Cap-3830P/E (TTM)

Intellia Therapeutics Key Stats

Intellia Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

Feb 22, 2024

Revenue(YoY)

-1.92M

-114.12%
EPS(YoY)

-1.46

-4.29%

Buy

Apr 10, 2024

Intellia Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 20 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 19.127M--
--2024/Q1-- / 9.065M--
Feb 22, 20242023/Q4-1.917M / 11.359M--
Nov 9, 20232023/Q311.992M / 11.953M--
Aug 3, 20232023/Q213.594M / 11.315M--
May 4, 20232023/Q112.606M / 11.122M--
Feb 23, 20232022/Q413.573M / 10.711M--
Nov 3, 20222022/Q313.266M / 10.930M--
Aug 4, 20222022/Q214.030M / 9.499M--
May 5, 20222022/Q111.252M / 8.569M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 19.127M--
--2024/Q1-- / 9.065M--
Feb 22, 20242023/Q4-1.917M / 11.359M--
Nov 9, 20232023/Q311.992M / 11.953M--
Aug 3, 20232023/Q213.594M / 11.315M--
May 4, 20232023/Q112.606M / 11.122M--
Feb 23, 20232022/Q413.573M / 10.711M--
Nov 3, 20222022/Q313.266M / 10.930M--
Aug 4, 20222022/Q214.030M / 9.499M--
May 5, 20222022/Q111.252M / 8.569M--

Unlock Free Earnings Estimates

Intellia Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 10, 2024

Buy

  • Buy

    70.59%
  • Hold

    29.41%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg